KDM1A and cancer: This evidence suggests that Nox subunit genes may be important targets of LSD1, a key finding that further implicates LSD1-dependent signaling pathways not only in atherogenesis, but also in other different pathologies associated with increased Nox expression, ROS overproduction, and oxidative stress (e.g., cancer, diabetes, hypertension, neurodegeneration).